These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
681 related items for PubMed ID: 16904389
1. Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells. Rickard DJ, Wang FL, Rodriguez-Rojas AM, Wu Z, Trice WJ, Hoffman SJ, Votta B, Stroup GB, Kumar S, Nuttall ME. Bone; 2006 Dec; 39(6):1361-72. PubMed ID: 16904389 [Abstract] [Full Text] [Related]
2. Dexamethasone and retinoic acid differentially regulate growth and differentiation in an immortalised human clonal bone marrow stromal cell line with osteoblastic characteristics. Ogston N, Harrison AJ, Cheung HF, Ashton BA, Hampson G. Steroids; 2002 Oct; 67(11):895-906. PubMed ID: 12234625 [Abstract] [Full Text] [Related]
3. Changes in osteoblast, chondrocyte, and adipocyte lineages mediate the bone anabolic actions of PTH and small molecule GSK-3 inhibitor. Kulkarni NH, Wei T, Kumar A, Dow ER, Stewart TR, Shou J, N'cho M, Sterchi DL, Gitter BD, Higgs RE, Halladay DL, Engler TA, Martin TJ, Bryant HU, Ma YL, Onyia JE. J Cell Biochem; 2007 Dec 15; 102(6):1504-18. PubMed ID: 17520664 [Abstract] [Full Text] [Related]
4. Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells. van der Horst G, Farih-Sips H, Löwik CW, Karperien M. J Bone Miner Res; 2005 Dec 15; 20(12):2233-44. PubMed ID: 16294276 [Abstract] [Full Text] [Related]
5. 3',5'-Cyclic adenosine monophosphate activation in osteoblastic cells: effects on parathyroid hormone-1 receptors and osteoblastic differentiation in vitro. Koh AJ, Beecher CA, Rosol TJ, McCauley LK. Endocrinology; 1999 Jul 15; 140(7):3154-62. PubMed ID: 10385409 [Abstract] [Full Text] [Related]
6. Climbing exercise enhances osteoblast differentiation and inhibits adipogenic differentiation with high expression of PTH/PTHrP receptor in bone marrow cells. Menuki K, Mori T, Sakai A, Sakuma M, Okimoto N, Shimizu Y, Kunugita N, Nakamura T. Bone; 2008 Sep 15; 43(3):613-20. PubMed ID: 18567552 [Abstract] [Full Text] [Related]
7. Immortalization of human marrow stromal cells by retroviral transduction with a temperature sensitive oncogene: identification of bipotential precursor cells capable of directed differentiation to either an osteoblast or adipocyte phenotype. Houghton A, Oyajobi BO, Foster GA, Russell RG, Stringer BM. Bone; 1998 Jan 15; 22(1):7-16. PubMed ID: 9437508 [Abstract] [Full Text] [Related]
8. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. Dang ZC, van Bezooijen RL, Karperien M, Papapoulos SE, Löwik CW. J Bone Miner Res; 2002 Mar 15; 17(3):394-405. PubMed ID: 11878304 [Abstract] [Full Text] [Related]
9. Glycogen synthase kinase-3α/β inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineage. Gambardella A, Nagaraju CK, O'Shea PJ, Mohanty ST, Kottam L, Pilling J, Sullivan M, Djerbi M, Koopmann W, Croucher PI, Bellantuono I. J Bone Miner Res; 2011 Apr 15; 26(4):811-21. PubMed ID: 20939016 [Abstract] [Full Text] [Related]
11. High extracellular Ca2+ enhances the adipocyte accumulation of bone marrow stromal cells through a decrease in cAMP. Hashimoto R, Katoh Y, Miyamoto Y, Nakamura K, Itoh S, Daida H, Nakazato Y, Okada T. Cell Calcium; 2017 Nov 15; 67():74-80. PubMed ID: 29029793 [Abstract] [Full Text] [Related]
13. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. Kondo H, Guo J, Bringhurst FR. J Bone Miner Res; 2002 Sep 15; 17(9):1667-79. PubMed ID: 12211438 [Abstract] [Full Text] [Related]
14. Osteogenic growth peptide C-terminal pentapeptide [OGP(10-14)] acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes. Chen ZX, Chang M, Peng YL, Zhao L, Zhan YR, Wang LJ, Wang R. Regul Pept; 2007 Jul 05; 142(1-2):16-23. PubMed ID: 17331598 [Abstract] [Full Text] [Related]
17. Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Justesen J, Stenderup K, Eriksen EF, Kassem M. Calcif Tissue Int; 2002 Jul 05; 71(1):36-44. PubMed ID: 12200657 [Abstract] [Full Text] [Related]